The Prostate Journal

An α-Particle Emitting Antibody ([²¹³Bi] J591) for Radioimmunotherapy of Prostate Cancer
pp. 1-1(1)
Author: George, Daniel J.

The Prostate Cancer Continuum: The Role of Bicalutamide (Casodex^®)
pp. 2-13(12)
Author: Kolvenbag, G. J. C. M.

Anemia Related to Hormonal Ablation Therapy for Prostate Cancer
pp. 14-17(4)
Author: Oh, William K.

Serum Prostate Specific Antigen as a Predictor of Survival in Prostate Cancer Patients Treated with Second-Line Hormonal Therapy (CALGB 9181)
pp. 18-25(8)
Authors: Halabi, Susan; Conaway, Mark R.; Small, Eric J.; Vogelzang, Nicholas J.; Dawson, Nancy A.

Trends in Prostate and Breast Cancer Clinical Research as Reported in the American Society of Clinical Oncology Proceedings
pp. 26-29(4)
Authors: Chlebowski, Rowan T.; Curti, Mario

Pilot Study of Oral Eniluracil/5-FU in the Palliation of Hormone-Refractory Prostate Cancer
pp. 30-35(6)
Authors: Rosenthal, Mark A.; Thomas, David; Davis, Ian; Toner, Guy; Noordin, Naeem; Zalcberg, John

Age-Specific Reference Ranges for Prostate Specific Antigen in Young Men: Retrospective Study from the National Defense University
pp. 36-41(6)
Authors: Hartzell, Joshua D.; Kao, Tzu-Cheg; Holland, John C.; Holt, Stephen R.; Moul, Judd W.

Bicalutamide Monotherapy Compared with Castration in Patients with Nonmetastatic Locally Advanced Prostate Cancer: 6.3 Years of Follow-up
pp. 42-43(2)
Authors: Gilligan, Timothy; Oh, William

Overall Survival after Prostate-Specific-Antigen-Detected Recurrence Following Conformal Radiation Therapy.
pp. 43-44(2)
Authors: Gilligan, Timothy; Oh, William

Prospective Trial of the Herbal Supplement PC-SPEC in Patients with Progressive Prostate Cancer.
pp. 44-45(2)
Authors: Gilligan, Timothy; Oh, William

Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer.
pp. 45-46(2)
Authors: Gilligan, Timothy; Oh, William

The Prostate Journal Database - William Oh, M.D.
pp. 47-50(4)

The Prostate Journal Calendar
pp. 51-51(1)